TOPO THERAPEUTICS
LIVE

Serial Number

98977477

Owner

Topo Therapeutics, Inc.

Attorney

Susan Weller

First Use Date

Sep 17, 2024

Filing Date

Jul 15, 2024

Add to watchlist:

No watchlists yet
View on USPTO

TOPO THERAPEUTICS Trademark

Serial Number: 98977477 • Registration: 8139101

TOPO THERAPEUTICS is a trademark filed by Topo Therapeutics, Inc. on July 15, 2024. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Topo Therapeutics, Inc. (2 trademarks)

1 Kendall Square
Cambridge, MA 02139

Entity Type: 03

Trademark Details

Filing Date

July 15, 2024

Registration Date

February 10, 2026

First Use Anywhere

September 17, 2024

First Use in Commerce

September 17, 2024

Published for Opposition

February 25, 2025

Goods & Services

Medical and pharmaceutical research services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and scientific research, namely, conducting clinical trials for others; laboratory research services relating to pharmaceuticals; scientific and technological services, namely, research and design services in the field of process development, validation, qualification, and manufacturing of pharmaceuticals and biopharmaceuticals; scientific and technological services consultation services in the field of development, manufacturing and testing of pharmaceuticals and biopharmaceuticals; providing product research and development in the pharmaceutical field for purposes of process development, validation, qualification, and manufacturing of pharmaceuticals and biopharmaceuticals; scientific and technological consultation services in the field of pharmaceutical research and pharmacology; custom development of pharmaceutical, biopharmaceutical and chemical products; pre-clinical and non-clinical evaluation testing of pharmaceutical, biopharmaceutical and chemical products performed primarily using animals and other biological models; pharmaceutical, biopharmaceutical, and chemical research and development for others; pharmaceutical research for the purpose of treating pain disorders, folding disorders, and secretory diarrhea; pharmaceutical research for use in pediatric, geriatric, emergency, family, and preventative medicine

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 10, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 10, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 22, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 22, 2026 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jan 22, 2026 SUPC
DIVISIONAL PROCESSING COMPLETE
Jan 22, 2026 DPCC
USE AMENDMENT FILED
Jan 21, 2026 IUAF
DIVISIONAL REQUEST RECEIVED
Jan 21, 2026 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Jan 21, 2026 ERTD
TEAS STATEMENT OF USE RECEIVED
Jan 21, 2026 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 9, 2026 EXRA
SOU EXTENSION 1 GRANTED
Jan 8, 2026 EX1G
SOU EXTENSION 1 FILED
Jan 8, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 8, 2026 EEXT
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 20, 2025 TEME
REVIEW OF CORRESPONDENCE COMPLETE
Nov 19, 2025 CORV
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 19, 2025 AITU
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 18, 2025 CRFA
TEAS POST PUBLICATION AMENDMENT RECEIVED
Sep 18, 2025 EPPA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 12, 2025 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 12, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 12, 2025 COAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 12, 2025 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jul 6, 2025 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Mar 26, 2025 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 25, 2025 NPUB
PUBLISHED FOR OPPOSITION
Feb 25, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 19, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 30, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 30, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 30, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 30, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 30, 2025 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 29, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jan 29, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jan 29, 2025 CNRT
ASSIGNED TO EXAMINER
Jan 28, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 15, 2025 NWOS
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 21, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 21, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 21, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 21, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 21, 2024 COAR
NEW APPLICATION ENTERED
Jul 15, 2024 NWAP